Alexander D. Barrow

3.7k total citations · 1 hit paper
38 papers, 2.8k citations indexed

About

Alexander D. Barrow is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Alexander D. Barrow has authored 38 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Alexander D. Barrow's work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (12 papers) and IL-33, ST2, and ILC Pathways (6 papers). Alexander D. Barrow is often cited by papers focused on Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (12 papers) and IL-33, ST2, and ILC Pathways (6 papers). Alexander D. Barrow collaborates with scholars based in United States, United Kingdom and Australia. Alexander D. Barrow's co-authors include Marco Colonna, John Trowsdale, Marina Cella, William Vermi, Claudia Martín, Susan Gilfillan, Kristy J. Szretter, Yaming Wang, Michael Diamond and Venugopal Nair and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Blood.

In The Last Decade

Alexander D. Barrow

37 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

2012 734 citations Yaming Wang, Kristy J. Szretter et al. Nature Immunology profile →

Peers

Alexander D. Barrow

IMMUN

ONCOL

NEURO

EPIDE

Melanie Laschinger Germany

Yu-Min Huang Sweden

Hervé Luche France

Meriem Garfa‐Traoré France

Deming Sun United States

Kutlu G. Elpek United States

Céline Trouillet United Kingdom

Marc Bajénoff France

Aaron J. Johnson United States

Clare Pridans United Kingdom

Melanie Laschinger Germany

Alexander D. Barrow

1.2k ×0.6

IMMUN

534 ×0.8

622 ×1.1

ONCOL

410 ×0.9

NEURO

159 ×0.7

EPIDE

Citations per year, relative to Alexander D. Barrow Alexander D. Barrow (= 1×) peers Melanie Laschinger

Countries citing papers authored by Alexander D. Barrow

Since Specialization

Citations

This map shows the geographic impact of Alexander D. Barrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander D. Barrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander D. Barrow more than expected).

Fields of papers citing papers by Alexander D. Barrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander D. Barrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander D. Barrow. The network helps show where Alexander D. Barrow may publish in the future.

Co-authorship network of co-authors of Alexander D. Barrow

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander D. Barrow. A scholar is included among the top collaborators of Alexander D. Barrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander D. Barrow. Alexander D. Barrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Md. Abdullah‐Al‐Kamran, J.P. Vivian, Alexandra J. Corbett, et al.. (2025). Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer. Frontiers in Immunology. 15. 1474652–1474652. 1 indexed citations

Khan, Md. Abdullah‐Al‐Kamran, et al.. (2023). cellsig plug-in enhances CIBERSORTx signature selection for multidataset transcriptomes with sparse multilevel modelling. Bioinformatics. 39(12). 2 indexed citations

Khan, Md. Abdullah‐Al‐Kamran, et al.. (2023). IL17RB and IL17REL Expression Are Associated with Improved Prognosis in HPV-Infected Head and Neck Squamous Cell Carcinomas. Pathogens. 12(4). 572–572. 1 indexed citations

Khan, Md. Abdullah‐Al‐Kamran, et al.. (2021). A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer. Frontiers in Immunology. 12. 724107–724107. 22 indexed citations

Ghazanfari, Nazanin, et al.. (2020). The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer. Frontiers in Immunology. 11. 1549–1549. 45 indexed citations

Barrow, Alexander D., Claudia Martín, & Marco Colonna. (2019). The Natural Cytotoxicity Receptors in Health and Disease. Frontiers in Immunology. 10. 909–909. 270 indexed citations

Barrow, Alexander D. & Marco Colonna. (2019). Exploiting NK Cell Surveillance Pathways for Cancer Therapy. Cancers. 11(1). 55–55. 40 indexed citations

Barrow, Alexander D. & Marco Colonna. (2018). Innate lymphoid cell sensing of tissue vitality. Current Opinion in Immunology. 56. 82–93. 13 indexed citations

Robinette, Michelle L., Marina Cella, Jean‐Baptiste Telliez, et al.. (2017). Jak3 deficiency blocks innate lymphoid cell development. Mucosal Immunology. 11(1). 50–60. 38 indexed citations

10.

Barrow, Alexander D., Melissa A. Edeling, Vladimir Trifonov, et al.. (2017). Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. 172(3). 534–548.e19. 202 indexed citations

11.

Barrow, Alexander D. & Marco Colonna. (2017). Tailoring Natural Killer cell immunotherapy to the tumour microenvironment. Seminars in Immunology. 31. 30–36. 30 indexed citations

12.

Wang, Yaming, Kristy J. Szretter, William Vermi, et al.. (2012). IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nature Immunology. 13(8). 753–760. 734 indexed citations breakdown →

13.

Barrow, Alexander D., Nicolas Raynal, Thomas Levin Andersen, et al.. (2011). OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. Journal of Clinical Investigation. 121(9). 3505–3516. 163 indexed citations

14.

Cao, Huan, Bernard de Bono, Katherine Belov, et al.. (2009). Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region. Immunogenetics. 61(5). 401–417. 37 indexed citations

15.

Eagle, Robert A., Anthony Warford, Jesús Martı́nez-Borra, et al.. (2009). Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G. PLoS ONE. 4(2). e4503–e4503. 38 indexed citations

16.

Eagle, Robert A., Insiya Jafferji, & Alexander D. Barrow. (2009). Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells. Current Immunology Reviews. 5(1). 22–34. 72 indexed citations

17.

Cao, Huan, et al.. (2008). SIGLEC16 encodes a DAP12‐associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non‐functional alleles in humans. European Journal of Immunology. 38(8). 2303–2315. 84 indexed citations

18.

Belov, Katherine, Claire Sanderson, Janine E. Deakin, et al.. (2007). Characterization of the opossum immune genome provides insights into the evolution of the mammalian immune system. Genome Research. 17(7). 982–991. 92 indexed citations

19.

Barrow, Alexander D. & John Trowsdale. (2006). You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. European Journal of Immunology. 36(7). 1646–1653. 205 indexed citations

20.

Barrow, Alexander D., Emmanuelle Astoul, A. Floto, et al.. (2004). Cutting Edge: TREM-Like Transcript-1, a Platelet Immunoreceptor Tyrosine-Based Inhibition Motif Encoding Costimulatory Immunoreceptor that Enhances, Rather than Inhibits, Calcium Signaling via SHP-2. The Journal of Immunology. 172(10). 5838–5842. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact